This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Guangzhou Cai Zhi Lin Corporation Bei Shang Chinese Raw Medicine Co., Ltd
Guangzhou Cai Zhi Lin Corporation Bei Shang Chinese Raw Medicine Co., Ltd., commonly referred to as Bei Shang, is a prominent player in the traditional Chinese medicine industry, headquartered in Guangzhou, China. Established in the early 2000s, the company has made significant strides in the sourcing and distribution of high-quality raw medicinal herbs, catering to both domestic and international markets. Specialising in a diverse range of herbal products, Bei Shang is renowned for its commitment to quality and authenticity, ensuring that each product meets rigorous industry standards. The company’s unique approach combines traditional practices with modern quality control measures, setting it apart in a competitive landscape. With a strong market presence, Bei Shang has achieved notable recognition for its contributions to the herbal medicine sector, solidifying its reputation as a trusted supplier of Chinese raw medicine.
DitchCarbon Score
How does Guangzhou Cai Zhi Lin Corporation Bei Shang Chinese Raw Medicine Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guangzhou Cai Zhi Lin Corporation Bei Shang Chinese Raw Medicine Co., Ltd's score of 2 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guangzhou Cai Zhi Lin Corporation Bei Shang Chinese Raw Medicine Co., Ltd currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, which may influence its climate commitments and emissions reporting. As part of its corporate family, any climate initiatives or emissions data would be inherited from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. However, no specific reduction targets or climate pledges have been documented for Guangzhou Cai Zhi Lin Corporation. This lack of data suggests that the company may still be in the early stages of developing its carbon management strategies or reporting frameworks. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction, often aligning with global standards such as the Science Based Targets initiative (SBTi). It is essential for Guangzhou Cai Zhi Lin Corporation to establish clear climate commitments and reduction targets to enhance its environmental performance and align with industry best practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Guangzhou Cai Zhi Lin Corporation Bei Shang Chinese Raw Medicine Co., Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
